北美宏基因组学市场至 2027 年 - 按产品(仪器、软件和消耗品)、应用(临床诊断、药物发现宏基因组学等)和国家/地区进行区域分析和预测

Historic Data: 2016-2017   |   Base Year: 2018   |   Forecast Period: 2019-2027


No. of Pages: 139    |    Report Code: TIPRE00003322    |    Category: Life Sciences

North America Metagenomics Market

北美宏基因组学市场预计将从 2018 年的 5520 万美元增至 2027 年的 1.069 亿美元。预计从 2018 年开始,该市场将以 8.0% 的复合年增长率增长 - 2027年。

北美地区对宏基因组学的投资增加以及宏基因组学的多样化应用等因素推动了市场的增长。然而,与宏基因组学相关的高成本可能会对未来几年市场的增长产生负面影响。

宏基因组学是生物技术和生物技术的新兴领域。世界各地的实验室正在进行广泛的研究。美国的几个临床实验室已经花费了相当长的时间来升级和验证各种协议,用于不可知地检测不同患者样本中的病毒、细菌、真菌和真核寄生虫核酸,以利于诊断特别棘手的病例。< /span>

广泛的研究需求正在推动风险投资或学术医疗中心补贴宏基因组测试的价格。他们帮助进行研究和测试,每个样本的费用为 2000 美元 - 3000 美元。

总部位于加利福尼亚州的 Illumina 等主要市场参与者已经推出了突破性技术,这些技术可以减少测序的成本和时间。例如,Illumina 的 NovaSeq 6000 测序系统发布了突破性创新。该系统几乎可以为任何测序方法、基因组和项目规模提供可访问的通量和灵活性。

由于宏基因组学的成本得到了风险投资家的补贴市场领导者提供的能够进行宏基因组研究的创新技术可能会在预测期内推动市场的增长。

预计美国将领先预测期内北美地区宏基因组学的采用情况。总部位于美国的主要参与者也致力于开发创新和新颖的产品并将其推向市场,这也是推动美国在北美宏基因组市场增长的主要因素之一。此外,这些公司正在大力投资研发,以推出源自天然微生物来源的医疗产品。例如,2018 年 8 月,Genentech 和 Lodo 启动了一个 10 亿美元的项目,利用土壤中发现的微生物 DNA 开发独特的天然产品。根据此次合作,基因泰克将利用 Lodo 的宏基因组勘探平台来识别具有治疗疾病潜力的新型小分子。

墨西哥宏基因组市场到 2027 年的收入和预测(十亿美元)



北美宏基因组学 - 市场细分



按产品


  • 仪器仪表软件
  • 消耗品

北美宏基因组学 - 市场细分



按应用


  • 临床诊断
  • 药物发现

按国家


  • 美国< /li>
  • 加拿大
  • 墨西哥

提及的公司

< /span>
  • 默克公司
  • 赛默飞世尔科技公司
  • 安捷伦科技
  • Qiagen
  • Bio-Rad Laboratories, Inc.
  • Perkinelmer Inc.
  • Illumina Inc.
  • F Hoffman-La Roche Ltd.
  • 牛津纳米孔技术有限公司
  • 加州太平洋生物科学公司


North America Metagenomics Strategic Insights

Strategic insights for North America Metagenomics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/north-america-metagenomics-market-strategic-framework.webp
Get more information on this report

North America Metagenomics Report Scope

Report Attribute Details
Market size in 2018 US$ 55.2 Million
Market Size by 2027 US$ 106.9 Million
Global CAGR (2018 - 2027) 8.0%
Historical Data 2016-2017
Forecast period 2019-2027
Segments Covered By 产品
  • 仪器
  • 软件和耗材
By 应用
  • 临床诊断
  • 药物发现宏基因组学
Regions and Countries Covered 北美
  • 美国
  • 加拿大
  • 墨西哥
Market leaders and key company profiles
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies
  • Qiagen
  • Bio-Rad Laboratories, Inc.
  • Perkinelmer Inc.
  • Illumina Inc.
  • F Hoffman-La Roche Ltd.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Bioscience of California, Inc.
  • Get more information on this report

    North America Metagenomics Regional Insights

    The regional scope of North America Metagenomics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/north-america-metagenomics-market-geography.webp
    Get more information on this report

    The List of Companies - North America Metagenomics Market

    The List of Companies - North America Metagenomics Market

    1. Merck KGaA
    2. Thermo Fisher Scientific Inc.
    3. Agilent Technologies
    4. Qiagen
    5. Bio-Rad Laboratories, Inc.
    6. Perkinelmer Inc.
    7. Illumina Inc.
    8. F Hoffman-La Roche Ltd.
    9. Oxford Nanopore Technologies Ltd.
    10. Pacific Bioscience of California, Inc.
    Frequently Asked Questions
    How big is the North America Metagenomics Market?

    The North America Metagenomics Market is valued at US$ 55.2 Million in 2018, it is projected to reach US$ 106.9 Million by 2027.

    What is the CAGR for North America Metagenomics Market by (2018 - 2027)?

    As per our report North America Metagenomics Market, the market size is valued at US$ 55.2 Million in 2018, projecting it to reach US$ 106.9 Million by 2027. This translates to a CAGR of approximately 8.0% during the forecast period.

    What segments are covered in this report?

    The North America Metagenomics Market report typically cover these key segments-

  • 产品 (仪器, 软件和耗材)
  • 应用 (临床诊断, 药物发现宏基因组学)
  • What is the historic period, base year, and forecast period taken for North America Metagenomics Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Metagenomics Market report:

  • Historic Period : 2016-2017
  • Base Year : 2018
  • Forecast Period : 2019-2027
  • Who are the major players in North America Metagenomics Market?

    The North America Metagenomics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies
  • Qiagen
  • Bio-Rad Laboratories, Inc.
  • Perkinelmer Inc.
  • Illumina Inc.
  • F Hoffman-La Roche Ltd.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Bioscience of California, Inc.
  • Who should buy this report?

    The North America Metagenomics Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the North America Metagenomics Market value chain can benefit from the information contained in a comprehensive market report.